BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
CONDITION

Evidence-Based Compounds for IBS

Irritable bowel syndrome involves gut-brain axis dysregulation, altered gut microbiome composition, increased intestinal permeability, and visceral hypersensitivity. Compounds with clinical evidence for reducing IBS symptoms through microbiome modulation, barrier repair, anti-spasmodic action, and anti-inflammatory mechanisms are ranked below.

Top 5 Compounds — Ranked by Evidence
Weighted ranking: BiohacksAI discovery score · pathway overlap · PubMed study count
Ranking Methodology
Compounds are ranked using a four-signal weighted model: BiohacksAI discovery score (cross-study convergence across targets), target match (direct overlap with TLR4, TRPV1, MUC2 and related targets — highest differentiating signal), pathway overlap with GUT MICROBIOME and INFLAMMATION pathways, and PubMed study count (log-scaled). Clinical drugs are excluded.
Key Biological Targets

Click a target to see all compounds with documented interactions in the BiohacksAI corpus.

This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.

Browse all compounds · Biological pathways · Molecular targets · All conditions

© Organiq Sweden AB · Patent pending EVE-PAT-2026-001